Scientists test direct liver attack on advanced melanoma
NCT ID NCT04812470
Summary
This early-stage study tested the safety of a new treatment for melanoma that has spread to the liver. Doctors took a patient's own tumor-fighting immune cells, grew more of them in a lab, and then infused them directly into the liver's blood supply. The main goal was to see if this procedure was safe and feasible for a small group of patients with advanced disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Oncology, Sahlgrenska University Hospital
Gothenburg, Sweden
Conditions
Explore the condition pages connected to this study.